These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32478203)

  • 1. Targeted delivery of chlorogenic acid by mannosylated liposomes to effectively promote the polarization of TAMs for the treatment of glioblastoma.
    Ye J; Yang Y; Jin J; Ji M; Gao Y; Feng Y; Wang H; Chen X; Liu Y
    Bioact Mater; 2020 Sep; 5(3):694-708. PubMed ID: 32478203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-free mannosylated liposomes inhibit tumor growth by promoting the polarization of tumor-associated macrophages.
    Ye J; Yang Y; Dong W; Gao Y; Meng Y; Wang H; Li L; Jin J; Ji M; Xia X; Chen X; Jin Y; Liu Y
    Int J Nanomedicine; 2019; 14():3203-3220. PubMed ID: 31118632
    [No Abstract]   [Full Text] [Related]  

  • 3. Chlorogenic acid inhibits glioblastoma growth through repolarizating macrophage from M2 to M1 phenotype.
    Xue N; Zhou Q; Ji M; Jin J; Lai F; Chen J; Zhang M; Jia J; Yang H; Zhang J; Li W; Jiang J; Chen X
    Sci Rep; 2017 Jan; 7():39011. PubMed ID: 28045028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted co-delivery of resiquimod and a SIRPα variant by liposomes to activate macrophage immune responses for tumor immunotherapy.
    Jia D; Lu Y; Lv M; Wang F; Lu X; Zhu W; Wei J; Guo W; Liu R; Li G; Wang R; Li J; Yuan F
    J Control Release; 2023 Aug; 360():858-871. PubMed ID: 37473808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral SMEDDS promotes lymphatic transport and mesenteric lymph nodes target of chlorogenic acid for effective T-cell antitumor immunity.
    Ye J; Gao Y; Ji M; Yang Y; Wang Z; Wang B; Jin J; Li L; Wang H; Xu X; Liao H; Lian C; Xu Y; Li R; Sun T; Gao L; Li Y; Chen X; Liu Y
    J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34272308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precise Delivery of Nanomedicines to M2 Macrophages by Combining "Eat Me/Don't Eat Me" Signals and Its Anticancer Application.
    Tang Y; Tang Z; Li P; Tang K; Ma Z; Wang Y; Wang X; Li C
    ACS Nano; 2021 Nov; 15(11):18100-18112. PubMed ID: 34751571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of chlorogenic acid-containing liposomes with prolonged antitumor immunity based on T cell regulation.
    Zhang Y; Yang Y; Ye J; Gao Y; Liao H; Zhou J; Feng Y; Liu D; Meng Y; Chen X; Gao L; Liu Y
    Sci China Life Sci; 2021 Jul; 64(7):1097-1115. PubMed ID: 33009993
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Gao Q; Zhang J; Chen C; Chen M; Sun P; Du W; Zhang S; Liu Y; Zhang R; Bai M; Fan C; Wu J; Men T; Jiang X
    ACS Nano; 2020 Apr; 14(4):3980-3990. PubMed ID: 32167741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing antibody-dependent cellular phagocytosis by Re-education of tumor-associated macrophages with resiquimod-encapsulated liposomes.
    Li H; Somiya M; Kuroda S
    Biomaterials; 2021 Jan; 268():120601. PubMed ID: 33338932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined immunochemotherapy achieving targeted co-delivery of chlorogenic acid and doxorubicin by sialic acid-modified liposomes enhances anti-cancer efficacy.
    Zhu S; Li X; Luo Z; Ding M; Shi S; Zhang T
    Drug Deliv Transl Res; 2024 Mar; 14(3):718-729. PubMed ID: 37679600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
    Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
    Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
    [No Abstract]   [Full Text] [Related]  

  • 12. Targeted Delivery of Dasatinib to Deplete Tumor-Associated Macrophages by Mannosylated Mixed Micelles for Tumor Immunotherapy.
    Zhang X; Zang X; Qiao M; Zhao X; Hu H; Chen D
    ACS Biomater Sci Eng; 2020 Oct; 6(10):5675-5684. PubMed ID: 33320562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supramolecular nanotherapeutics enable metabolic reprogramming of tumor-associated macrophages to inhibit tumor growth.
    Ramesh A; Malik V; Brouillard A; Kulkarni A
    J Biomed Mater Res A; 2022 Aug; 110(8):1448-1459. PubMed ID: 35388955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repolarizing Tumor-Associated Macrophages and inducing immunogenic cell Death: A targeted liposomal strategy to boost cancer immunotherapy.
    Li C; Wang L; Li Z; Li Z; Zhang K; Cao L; Wang Z; Shen C; Chen L
    Int J Pharm; 2024 Feb; 651():123729. PubMed ID: 38142016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual Inhibition of Endoplasmic Reticulum Stress and Oxidation Stress Manipulates the Polarization of Macrophages under Hypoxia to Sensitize Immunotherapy.
    Jiang M; Li X; Zhang J; Lu Y; Shi Y; Zhu C; Liu Y; Qin B; Luo Z; Du Y; Luo L; Peng L; You J
    ACS Nano; 2021 Sep; 15(9):14522-14534. PubMed ID: 34414762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Streptococcus virulence protein PepO triggers anti-tumor immune responses by reprograming tumor-associated macrophages in a mouse triple negative breast cancer model.
    Liu B; Huang J; Xiao J; Xu W; Zhang H; Yuan Y; Yin Y; Zhang X
    Cell Biosci; 2023 Nov; 13(1):198. PubMed ID: 37925462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gold nanoparticle-directed autophagy intervention for antitumor immunotherapy
    Zhang S; Xie F; Li K; Zhang H; Yin Y; Yu Y; Lu G; Zhang S; Wei Y; Xu K; Wu Y; Jin H; Xiao L; Bao L; Xu C; Li Y; Lu Y; Gao J
    Acta Pharm Sin B; 2022 Jul; 12(7):3124-3138. PubMed ID: 35865102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted ferritin nanoparticle encapsulating CpG oligodeoxynucleotides induces tumor-associated macrophage M2 phenotype polarization into M1 phenotype and inhibits tumor growth.
    Shan H; Dou W; Zhang Y; Qi M
    Nanoscale; 2020 Nov; 12(43):22268-22280. PubMed ID: 33146206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor microcalcification-mediated relay drug delivery for photodynamic immunotherapy of breast cancer.
    Jian H; Wang X; Song P; Wu X; Zheng R; Wang Y; Zhang H
    Acta Biomater; 2022 Mar; 140():518-529. PubMed ID: 34923096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual inhibition of CSF1R and MAPK pathways using supramolecular nanoparticles enhances macrophage immunotherapy.
    Ramesh A; Brouillard A; Kumar S; Nandi D; Kulkarni A
    Biomaterials; 2020 Jan; 227():119559. PubMed ID: 31670078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.